Article

1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    2 1 0 0


Revue du rhumatisme
Volume 83, n° 1
pages 79-80 (janvier 2016)
Doi : 10.1016/j.rhum.2015.04.019
accepted : 7 April 2015
Deux premiers cas de pelade survenus sous golimumab
 

Carole Huynh a, , Ziad Reguiai b, Isabelle Lambrecht a, Pascal Brochot a, Jean-Paul Eschard a, Jean-Hugues Salmon a, c
a Service de rhumatologie, hôpital Maison-Blanche, CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France 
b Service de dermatologie, hôpital Robert-Debré, CHU de Reims, avenue du Général-Koenig, 51092 Reims cedex, France 
c EA 3797, faculté de médecine, université de Reims Champagne-Ardenne, 51095 Reims, France 

Auteur correspondant.

Mots clés : Pelade, Polyarthrite rhumatoïde, Anti-TNF alpha, Golimumab, Effet secondaire



 Ne pas utiliser, pour citation, la référence française de cet article mais la référence anglaise de Joint Bone Spine avec le DOI ci-dessus.



© 2015  Société Française de Rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline